Sign in
Taking people in United StatesEarly phase 1

Studies how sex and obesity affect blood vessel widening in low oxygen

Studies nerve system effects on blood vessel widening in adults with obesity.

Key facts

Who runs it
University of Missouri-Columbia
Where
Columbia, United StatesSee the site
Trial code
Registry title
Sex Disparities in Hypoxic Vasodilation and Impact of Obesity
Status
Recruiting
Phase
Early phase 1
People taking part
72 people, planned
Started
14 Mar 2023
Expected to end
30 Jul 2027
Type of study
Interventional
Treatments tested
  • Propranolol Hydrochloride
  • Isoproterenol
  • Phentolamine Mesylate
  • Norepinephrine
Record updated
28 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18 to 45 with a BMI above 18 kg/m2 and without major health problems. It studies sex differences in how blood vessels widen when oxygen is low, and the effect of obesity.

Age
18 Years to 45 Years
Sex
All sexes can join.
Earlier treatment
People taking prescription medications cannot join. People on anticoagulation therapy cannot join.

Main reasons for not taking part

  • Pregnancy or breastfeeding
  • Diagnosed sleep apnea or AHI >10 events/hr
  • Current smoking or nicotine use
  • Cardiovascular, liver, kidney or lung disease, or blood pressure ≥140/90 mmHg
  • Diabetes or polycystic ovarian syndrome

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • BMI >18 kg/m2

Who cannot take part

  • Prescription medications, Sensitivity to lidocaine
  • Increased risk of bleeding, pro-coagulant disorders, clotting disorders, anticoagulation therapy
  • Nerve/neurologic disease
  • Cardiovascular, hepatic, renal, respiratory disease
  • Diabetes, Polycystic ovarian syndrome
  • Pregnancy, breastfeeding
  • Diagnosed sleep apnea or AHI >10 events/hr
  • Current smoking/Nicotine use
  • Blood pressure ≥140/90 mmHg
  • Communication barriers

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 45 years old?

Where in United States

  • University of MissouriColumbia, United StatesContact: Jennifer L HarperTaking people

About the trial

What the trial wants to find out

The purpose of this project is to examine key mechanisms contributing to sex-differences in hypoxic vasodilation and the impact of obesity, with particular emphasis on the sympathetic nervous system.

The group in the trial

  • Hypoxia ExposureOther group

    Men and women will be exposed to isocapnic hypoxia. Participants will wear a mask and systemic oxygen levels will be titrated to attain hypoxemia as assessed by pulse oximetry.

    Treatment: Propranolol Hydrochloride, Isoproterenol, Phentolamine Mesylate, and Norepinephrine

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Sex Disparities in Hypoxic Vasodilation and Impact of Obesity
Plain-language title
Studies how sex and obesity affect blood vessel widening in low oxygenGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT05219799, who can take part
Record updated
28 July 2026